C

Clarity Pharmaceuticals Ltd
ASX:CU6

Watchlist Manager
Clarity Pharmaceuticals Ltd
ASX:CU6
Watchlist
Price: 2.39 AUD 14.35%
Market Cap: 768m AUD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

CU6 Price Targets Summary
Clarity Pharmaceuticals Ltd

Wall Street analysts forecast CU6 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CU6 is 6.79 AUD with a low forecast of 4.75 AUD and a high forecast of 9.14 AUD.

CU6 Lowest Forecast
Wall Street Target
4.75 AUD
99% Upside
CU6 Average Forecast
Wall Street Target
6.79 AUD
184% Upside
CU6 Highest Forecast
Wall Street Target
9.14 AUD
282% Upside
Lowest
Price Target
4.75 AUD
99% Upside
Average
Price Target
6.79 AUD
184% Upside
Highest
Price Target
9.14 AUD
282% Upside
Clarity Pharmaceuticals Ltd Competitors:
Price Targets
IOLCP
IOL Chemicals and Pharmaceuticals Ltd
4% Downside
K
KILITCH
Kilitch Drugs (India) Ltd
8% Downside
LQDA
Liquidia Corp
145% Upside
M
4016
Middle East Pharmaceutical Industries Company SJSC
12% Upside
IOLCP
IOL Chemicals and Pharmaceuticals Ltd
4% Downside
K
KILITCH
Kilitch Drugs (India) Ltd
8% Downside
LQDA
Liquidia Corp
145% Upside
M
4016
Middle East Pharmaceutical Industries Company SJSC
12% Upside
DMP
Dermapharm Holding SE
33% Upside
AMIORG
Ami Organics Ltd
28% Upside

Revenue
Forecast

Revenue Estimate
Clarity Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Clarity Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Clarity Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
What are analyst estimates?

See Also

Summary
CU6 intrinsic value, competitors valuation, and company profile.
DCF Valuation
CU6 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CU6 stock valuation using valuation multiples.
Wall Street Estimates
CU6 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CU6 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CU6's stock price target?
Price Target
6.79 AUD

According to Wall Street analysts, the average 1-year price target for CU6 is 6.79 AUD with a low forecast of 4.75 AUD and a high forecast of 9.14 AUD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 264,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.